What's Hot in the December Issue
Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort Study
Tine Jess, MD, DrSci, Erzsébet Horváth-Puhó, MSc, PhD, Jan Fallingborg, MD, DrSci, Henrik H. Rasmussen, MD, PhD and Bent A. Jacobsen, MD
This cohort study showed that patients with Crohn’s disease, but not ulcerative colitis, have an overall excess risk of cancer. Clinical characteristics of IBD patients at excess risk differ by cancer subtype.